Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices
Production & Manufacturing
Manufacturing
Return to: PBR Home | Production & Manufacturing | Manufacturing

Manufacturing

European Commission approves GSK and Novartis' three-part transaction By PBR Staff Writer
UK-based GlaxoSmithKline has received clearance from the European Commission (EC) for its proposed three-part transaction with Swiss drug-maker Novartis.
Production & Manufacturing > Manufacturing > News
Takeda launches Fomepizole Intravenous Infusion 1.5g in Japan Takeda Pharmaceutical Company announced that Fomepizole Intravenous Infusion 1.5g "Takeda" is now available for the treatment of ethylene glycol and methanol poisonings in Japan.
Production & Manufacturing > Manufacturing > News Eisai, Ajinomoto launch Livamin oral granules in Philippines Eisai and Ajinomoto Pharmaceuticals announced that LIVAMIN Oral Granules (granules of isoleucine, leucine and valine, brand name in Japan: LIVACT Granules), a branched-chain amino acid formula, was launched in the Philippines.
Production & Manufacturing > Manufacturing > News
See more Manufacturing news

Latest Manufacturing News and Insight

View all Manufacturing news or find news targeted to your interests
Scientist finds way to improve antibiotics to treat staph infections
By PBR Staff Writer
A scientist from the Saint Louis University in the US has discovered new information about how antibiotics like azithromycin can stop staph infections including the reason why staph sometimes becomes resistant to drugs.
Production & Manufacturing > Manufacturing > News
EMA recommends sale suspension of medicines based on GVK Bio’s ‘flawed’ clinical data
By PBR Staff Writer
The European Medicines Agency has recommended suspension of sale of around 700 medicines whose authorization was given based on clinical trial conducted by Hyderabad, India based GVK Biosciences.
Production & Manufacturing > Manufacturing > News
Novartis' Jakavi recommended by CHMP for EU approval to treat polycythemia vera
The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a positive opinion for Jakavi (ruxolitinib) for the treatment of adult patients with polycythemia vera (PV) who are resistant to or intolerant of hydroxyurea.
Production & Manufacturing > Manufacturing > News
VisiVite reports launch of ProVision macular health formula
VisiVite, a world leader in ocular nutrition, announced its upcoming January 2015 release of ProVision, a professional macular health formula designed to be easy for eye doctors to dispense and affordable for their patients to use.
Production & Manufacturing > Manufacturing > News
AMRI gets NIH contract for drug development and manufacturing services
Albany Molecular Research (AMRI) announced it received a 10-year federal contract award from the National Institutes of Health (NIH) for drug development and manufacturing services.
Production & Manufacturing > Manufacturing > News
Piramal to acquire Coldstream Laboratories for $30.65m
By PBR Staff Writer
India-based Piramal Enterprises, through its US subsidiary is planning to acquire Coldstream Laboratories from University of Kentucky for $30.65m in an all cash transaction.
Production & Manufacturing > Manufacturing > News
AbbVie secures European approval to market VIEKIRAX + EXVIERA to treat HCV
By PBR Staff Writer
AbbVie has secured marketing authorization from the European Commission (EC) for its all-oral, short-course, interferon-free treatment of VIEKIRAX (ombitasvir/paritaprevir/ritonavir tablets) + EXVIERA (dasabuvir tablets) to treat patients with genotype 1 (GT1) chronic hepatitis C virus (HCV) infection.
Production & Manufacturing > Manufacturing > News
Mylan introduces Lamivudine Tablets, 100mg to treat hepatitis B virus
By PBR Staff Writer
US-based pharmaceutical firm Mylan has introduced its Lamivudine Tablets, 100mg, which is the generic version of GlaxoSmithKline's Epivir-HBV.
Production & Manufacturing > Manufacturing > News
Roche invests $1.03bn to buy majority stake in Foundation Medicine
By PBR Staff Writer
Swiss drugmaker Roche is investing $1.03bn to acquire a 56.3% stake in US-based Foundation Medicine to get access to genomic tests for screening tumors as well as to develop a new generation of treatments to combat cancer.
Production & Manufacturing > Manufacturing > News
View all Manufacturing news or find news targeted to your interests

Buy the latest industry research online today!
Shire Plc : Pharmaceuticals & Healthcare - Company Profile, SWOT & Financial Report 03 October 2013 This report is a crucial resource for industry executives and anyone looking to access key information about "Shire Plc" The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. ICD Research strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report. Buy online from $250